Business Opportunity
3D histological biomarkers for precision medicine
Our goal is to validate the prognostic and predictive accuracy of histological biomarkers in 3D, exploiting our scalable 3D histology solution. This approach will solve the sampling bias inherent in state-of-the art 2D histological approaches
- AI
- TRL 6
- Oncology
- Proteomics
- Diagnostics
- Clinical validation
- Consortium partners
- Neoplasms/cancer/oncology
CSO at Clepio Biotech Srl
Rome, Italy